These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 18196747

  • 1. Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.
    Hosoya K, Kisseberth WC, Lord LK, Alvarez FJ, Lara-Garcia A, Kosarek CE, London CA, Couto CG.
    J Vet Intern Med; 2007; 21(6):1355-63. PubMed ID: 18196747
    [Abstract] [Full Text] [Related]

  • 2. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD, Ogilvie GK, Mallinckrodt CH, Getzy DM.
    J Am Vet Med Assoc; 1997 Feb 15; 210(4):512-6. PubMed ID: 9040837
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
    Garrett LD, Thamm DH, Chun R, Dudley R, Vail DM.
    J Vet Intern Med; 2002 Feb 15; 16(6):704-9. PubMed ID: 12465768
    [Abstract] [Full Text] [Related]

  • 4. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
    Wang SL, Lee JJ, Liao AT.
    Vet J; 2016 Jul 15; 213():87-9. PubMed ID: 27240922
    [Abstract] [Full Text] [Related]

  • 5. Gastrointestinal and hematologic adverse events after administration of vincristine, cyclophosphamide, and doxorubicin in dogs with lymphoma that underwent a combination multidrug chemotherapy protocol.
    Tomiyasu H, Takahashi M, Fujino Y, Ohno K, Tsujimoto H.
    J Vet Med Sci; 2010 Nov 15; 72(11):1391-7. PubMed ID: 20543531
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB, Rassnick KM, Erb HN, Garrett LD, Northrup NC, Selting KA, Phillips BS, Locke JE, Chretin JD.
    J Am Vet Med Assoc; 2011 Feb 15; 238(4):501-6. PubMed ID: 21320021
    [Abstract] [Full Text] [Related]

  • 7. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma.
    Wang SL, Lee JJ, Liao AT.
    Vet J; 2015 Jul 15; 205(1):69-73. PubMed ID: 26004824
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT, Mauldin GE, Mauldin GN, Brodsky EM, Post GS.
    Vet Comp Oncol; 2010 Mar 15; 8(1):11-22. PubMed ID: 20230577
    [Abstract] [Full Text] [Related]

  • 9. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
    Wang SL, Lee JJ, Liao AT.
    Can Vet J; 2016 Mar 15; 57(3):271-6. PubMed ID: 26933263
    [Abstract] [Full Text] [Related]

  • 10. Comparison of a CHOP-LAsp-based protocol with and without maintenance for canine multicentric lymphoma.
    Lautscham EM, Kessler M, Ernst T, Willimzig L, Neiger R.
    Vet Rec; 2017 Mar 25; 180(12):303. PubMed ID: 28100766
    [Abstract] [Full Text] [Related]

  • 11. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
    Zemann BI, Moore AS, Rand WM, Mason G, Ruslander DM, Frimberger AE, Wood CA, L'Heureux DA, Gliatto J, Cotter SM.
    J Vet Intern Med; 1998 Mar 25; 12(6):465-70. PubMed ID: 9857340
    [Abstract] [Full Text] [Related]

  • 12. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.
    Lurie DM, Gordon IK, Théon AP, Rodriguez CO, Suter SE, Kent MS.
    J Vet Intern Med; 2009 Mar 25; 23(5):1064-70. PubMed ID: 19627472
    [Abstract] [Full Text] [Related]

  • 13. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
    Simon D, Nolte I, Eberle N, Abbrederis N, Killich M, Hirschberger J.
    J Vet Intern Med; 2006 Mar 25; 20(4):948-54. PubMed ID: 16955821
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.
    Burton JH, Garrett-Mayer E, Thamm DH.
    Vet Comp Oncol; 2013 Dec 25; 11(4):306-15. PubMed ID: 22548975
    [Abstract] [Full Text] [Related]

  • 15. Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma?
    Hahn KA, Richardson RC, Teclaw RF, Cline JM, Carlton WW, DeNicola DB, Bonney PL.
    J Vet Intern Med; 1992 Dec 25; 6(1):3-10. PubMed ID: 1548624
    [Abstract] [Full Text] [Related]

  • 16. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma.
    Parker AS, Burton JH, Curran KM, Wolf-Ringwall A, Thamm DH.
    J Vet Intern Med; 2024 Dec 25; 38(4):2282-2292. PubMed ID: 38961691
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
    Chun R, Garrett LD, Vail DM.
    J Vet Intern Med; 2000 Dec 25; 14(2):120-4. PubMed ID: 10772481
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy with cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) in childhood acute lymphoblastic leukemia (ALL).
    Sallan SE, Camitta BM, Chan DM, Traggis D, Jaffe N.
    Med Pediatr Oncol; 1977 Dec 25; 3(4):359-64. PubMed ID: 270608
    [Abstract] [Full Text] [Related]

  • 19. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
    Sorenmo K, Overley B, Krick E, Ferrara T, LaBlanc A, Shofer F.
    Vet Comp Oncol; 2010 Sep 25; 8(3):196-208. PubMed ID: 20691027
    [Abstract] [Full Text] [Related]

  • 20. Comparison of combination l-asparaginase plus CHOP or modified MOPP treatment protocols in dogs with multi-centric T-cell or hypercalcaemic lymphoma.
    Angelo G, Cronin K, Keys D.
    J Small Anim Pract; 2019 Jul 25; 60(7):430-437. PubMed ID: 30790291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.